Find Clinical Trials & Studies
Hidradenitis Suppurative CEDAR Study – Insmed
I'm Interested!
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults with Moderate to Severe Hidradenitis Suppurativa – The CEDAR Study
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase II
- Conditions Being Studied: Hidradenitis Suppurativa (HS)
Study Purpose
The purpose of this research study is to purpose of this study is to find out if the experimental drug (brensocatib) reduces the severity of HS, improves symptoms of HS, and is safe and well tolerated with long term use.
Who Can Participate
Participants between 18 and 80 years old diagnosed with HS may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
- UH IRB: STUDY20250575
- StudyID: 2024-01592
- ClinicalTrials.gov: NCT06685835
I'm Interested!
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422